IAP
Indie Asset Partners’s ADC Therapeutics ADCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-92,700
| Closed | -$154K | – | 87 |
|
|
2023
Q4 | $154K | Hold |
92,700
| – | – | 0.14% | 80 |
|
|
2023
Q3 | $83.2K | Sell |
92,700
-1,139
| -1% | -$1.02K | 0.08% | 74 |
|
|
2023
Q2 | $202K | Hold |
93,839
| – | – | 0.22% | 76 |
|
|
2023
Q1 | $183K | Hold |
93,839
| – | – | 0.21% | 81 |
|
|
2022
Q4 | $360K | Hold |
93,839
| – | – | 0.39% | 49 |
|
|
2022
Q3 | $452K | Sell |
93,839
-150
| -0.2% | -$723 | 0.46% | 39 |
|
|
2022
Q2 | $747K | Sell |
93,989
-2,583
| -3% | -$20.5K | 0.66% | 26 |
|
|
2022
Q1 | $1.42M | Sell |
96,572
-10
| -0% | -$147 | 1.07% | 13 |
|
|
2021
Q4 | $1.95M | Sell |
96,582
-829
| -0.9% | -$16.7K | 1.42% | 10 |
|
|
2021
Q3 | $2.65M | Buy |
97,411
+5,770
| +6% | +$157K | 2.14% | 7 |
|
|
2021
Q2 | $2.23M | Sell |
91,641
-475
| -0.5% | -$11.6K | 1.81% | 8 |
|
|
2021
Q1 | $2.25M | Sell |
92,116
-171
| -0.2% | -$4.18K | 2.56% | 6 |
|
|
2020
Q4 | $2.95M | Buy |
+92,287
| New | +$2.95M | 3.44% | 5 |
|